Supported by an educational grant from Sunovion Pharmaceuticals Inc.
Patients with bipolar disorder spend more time in depression than mania or hypomania and tend to seek treatment during depressive episodes more often than during manic periods. There is often a discrepancy between real-world management of bipolar depression and evidence-based recommendations. Treating patients with bipolar depression ideally requires a partnership between the patient and the clinician, including shared decision-making. This interactive case highlights data-supported treatment options and effective patient dialogues that can help identify and respond to the patient’s individual needs and improve outcomes for bipolar depression.
Psychiatrists, nurse practitioners, physician assistants, and other healthcare professionals working in a specialty setting who manage patients with bipolar depression.
At the conclusion of this activity, participants should be better able to:
Construct individualized, evidence-based treatment plans for patients with bipolar I depression, assessing the data for approved and nonapproved therapies
Employ strategies for a patient-centric approach and more effective patient/caregiver communication with regard to treatment options, adherence, and improving outcomes and quality of life
Conflict Of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
W. Clay Jackson, MD, DipTh, FAAFP Clinical Assistant Professor of Family Medicine & Psychiatry University of Tennessee College of Medicine Memphis, TN
The staff, planners, and reviewer at Haymarket Medical Education have no relevant financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Haymarket Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM. Physicians should claim only those credits commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Sunovion Pharmaceuticals Inc. and HME do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Sunovion Pharmaceuticals Inc. and HME. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.